Cardinal Health Inc vs Sea Limited — how do they compare? Cardinal Health Inc trades at $237.28 (market cap $55.88B), while Sea Limited trades at $129.76 (market cap $80.55B). The key difference: Sea Limited is the larger of the two by market cap, and Cardinal Health Inc pays a 0.86% dividend while Sea Limited pays none. Which is the better fit depends on your goals.
| CAH | SE | |
|---|---|---|
Market Cap | $55.88B | $80.55B |
Sector | Health | Media |
52-Week High | $240.26 | $196.50 |
52-Week Low | $146.04 | $78.16 |
Enterprise Value | $59.91B | $75.58B |
Dividend Yield | 0.86% | — |
Signals from Pluang's Aura AI — not financial advice
Cardinal Health (CAH) trades at $236.87, down 0.13% on the day, near its 52-week high. The stock shows strong momentum with four consecutive quarterly EPS beats, including Q2 2026 EPS of $2.91 versus $2.42 expected. Technical indicators are bullish overall, with moving averages supporting upward trends. Revenue reached $222.58 billion in 2025, with net income margin improving to 0.67%.
Outlook remains positive driven by robust pharmaceutical demand and optimistic FY2027 guidance. Key risks include high debt levels and thin profit margins. Analysts maintain a bullish consensus with a $266.43 price target, representing 12.5% upside. The stock presents a growth opportunity but requires monitoring of margin pressures and cash flow volatility.
Sea Limited (SE) stock surged 12.11% to $128.7, driven by strong Q2 2026 results with revenue of $7.8 billion, up 48% year-over-year. The company demonstrated robust growth across e-commerce, fintech, and gaming segments, with net income rising 11% to $458 million. Technical indicators show a bullish trend, though RSI levels suggest overbought conditions. Analyst consensus remains positive with a $128.33 price target, supported by improved EBITDA guidance for Shopee.
The outlook for SE is favorable due to accelerating revenue growth and diversification, but risks include margin pressure from increased investments and credit costs. The stock's high P/E ratio of 50.78 demands sustained earnings expansion. Insider selling by the COO warrants monitoring. Overall, growth prospects outweigh near-term challenges, positioning SE for potential upside if execution continues.
Trailing returns across standard periods
Latest headlines on both assets
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →Sea Limited offers information technology services. The Company provides online personal computer and mobile digital content, e-commerce, and payment platforms. Sea serves customers worldwide.
Read more on SE →